Hamilton Medical Center

Recent papers from Hamilton Medical Center

1. Histologic Features and Clinical Outcomes of Lean Metabolic Dysfunction–Associated Steatotic Liver DiseaseJAMA · 2026
2. Eosinophilic Esophagitis and Marked Leukocytosis in Alpha-Gal Syndrome: Infection, Allergy, or Hematologic Malignancy?Cureus · 2026
3. Diagnostic Accuracy of Fat Pad Sampling and Bone Marrow Biopsy for AL Amyloidosis: A Systematic Review and Meta-AnalysisBlood Advances · 2026
4. A replicable colectomy surgical site infection prevention bundle: Implementation and electronic health record--enabled compliance monitoringAmerican Journal of Infection Control · 2026
5. Early versus delayed biologic therapy for immune checkpoint inhibitor–associated colitis: A propensity-matched real-world analysis.Journal of Clinical Oncology · 2026
6. Factors influencing early readmission among breast, lung, and colorectal cancer patients admitted for febrile neutropenia: A Nationwide Readmissions Database (NRD) analysis.Journal of Clinical Oncology · 2026
7. Prevalence of non-treatment following pancreatic cancer diagnosis in the United States: A population-based analysis, 2016–2022.Journal of Clinical Oncology · 2026
8. Comparative outcomes of continuous infusion versus intravenous push followed by infusion 5-fluorouracil in patients with pancreatic and colon cancer: A propensity-matched analysis.Journal of Clinical Oncology · 2026
9. Safety and efficacy of full-dose apixaban vs rivaroxaban for cancer-associated venous thromboembolism in patients with solid tumors: A real-world study.Journal of Clinical Oncology · 2026
10. Patient-reported outcome planning and reporting in CAR-T and CD3xCD20 bispecific antibody trials for relapsed/refractory lymphoma: A cross-sectional analysis (2017–2025).Journal of Clinical Oncology · 2026
11. Overall survival and treatment-related outcomes with FOLFIRINOX compared with gemcitabine/nab-paclitaxel in metastatic pancreatic cancer.Journal of Clinical Oncology · 2026
12. The trade-offs between efficacy and toxicity: Real-world outcomes of dapsone vs atovaquone for pneumocystis prophylaxis in hematologic malignancies.Journal of Clinical Oncology · 2026
13. Denosumab versus zoledronic acid in patients with breast cancer: A propensity-matched real-world time-to-event analysis.Journal of Clinical Oncology · 2026
14. Pre-emptive and Prophylactic Strategies to Prevent Cardiovascular and Neurotoxicity in Chimeric Antigen Receptor T-Cell Therapy: The Role of Tocilizumab, Anakinra, and Cytokine-Targeted InterventionsCardiology in Review · 2026
15. Frailty, Sarcopenia, and Functional Decline After CAR-T Therapy: The Case for Structured RehabilitationCardiology in Review · 2026
16. Global Longitudinal Strain as a Surveillance Tool in Hematologic Cancer-Related CardiotoxicityCardiology in Review · 2026
17. Myeloproliferative Neoplasms, Clonal Thrombosis, and Vascular Disease: Can Cardiology Learn from Hematology?2026
18. Manifest Preexcitation‐Related Cardiac Dysfunction in the Absence of Tachyarrhythmia: A Systematic Review of LiteratureJournal of Cardiovascular Electrophysiology · 2026
19. Exosomes and Extracellular Vesicles in CAR-T Cell Therapy: Emerging Mediators and Biomarkers of Cardiac InjuryCardiology in Review · 2026
20. Diagnostic Utility of Immunofixation and Free Light Chain Assay in AL Amyloidosis: A Systematic Review and Meta-analysisBlood Advances · 2026